|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8820 EUR | -0.68% |
|
-3.08% | -42.58% |
| 10/06 | AB Science presents new data on Masitinib |  |
| 18/05 | AB Science S.A. announced that it has received $2.989368 million in funding | CI |
Company Valuation: AB Science
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 895.3 | 332.2 | 180.9 | 57.55 | 67.97 | 67.97 | - |
| Change | - | - | -45.55% | -68.19% | 18.1% | 0% | - |
| Enterprise Value (EV) | 895.3 | 332.2 | 180.9 | 57.55 | 67.97 | 67.97 | 67.97 |
| Change | - | - | -45.55% | -68.19% | 18.1% | 0% | 0% |
| P/E Ratio | - | -24.4x | -17.8x | -5.88x | - | - | - |
| PBR | - | - | - | - | - | - | - |
| PEG | - | - | 0.6x | 0.2x | - | - | - |
| Capitalization / Revenue | 566x | - | 187x | 53.7x | 95.4x | 56.6x | 52.3x |
| EV / Revenue | 0x | - | 0x | 0x | 61.8x | 56.6x | 52.3x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | - | - | -0x | -0x | -11.3x | -10.5x | -10.6x |
| EV / FCF | - | - | -0x | - | -11.3x | -10.6x | -18.9x |
| FCF Yield | - | - | -9.52% | - | -4.08% | -9.42% | -5.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | - | -0.29 | -0.2 | -0.15 | - | - | - |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 1.583 | - | 0.97 | 1.072 | 1.174 | 1.2 | 1.3 |
| EBITDA | - | - | -11.16 | -5.416 | - | - | - |
| EBIT 1 | - | - | -13.43 | -6.083 | 0.639 | -6.5 | -6.4 |
| Net income | - | -13.62 | -10.05 | -7.831 | - | - | - |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 19.6600 | 7.0900 | 3.5550 | 0.8820 | 0.8880 | 0.8880 | 0.8880 |
| Nbr of stocks (in thousands) | 45,540 | 46,861 | 50,891 | 65,248 | 76,539 | 76,539 | - |
| Announcement Date | 30/04/21 | 01/03/23 | 15/05/24 | 13/05/25 | 13/05/26 | - | - |
1EUR in Million2EUR
Estimates
P/E Ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 7.83Cr | |
| 22.87x | 3.16x | 11.21x | 1.72% | 6.78TCr | |
| 10.51x | 5.41x | 8.33x | - | 838.95Cr | |
| 15.74x | 1.97x | 6.77x | 2.83% | 792.17Cr | |
| 22.63x | 6.67x | 18.24x | -.--% | 452.92Cr | |
| 42.42x | 2.4x | 29.26x | 0.72% | 372.33Cr | |
| 28.24x | 5.41x | 15.46x | - | 327.86Cr | |
| 105.12x | - | - | -.--% | 264.37Cr | |
| Average | 35.36x | 4.17x | 14.88x | 1.06% | 1.23TCr | |
| Weighted average by Cap. | 24.36x | 3.47x | 11.77x | 1.64% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AB Stock
- Valuation AB Science
Select your edition
All financial news and data tailored to specific country editions
